These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2223632)

  • 41. Assessment of hematologic progenitor engraftment by complete reticulocyte maturation parameters after autologous and allogeneic hematopoietic stem cell transplantation.
    Torres A; Sánchez J; Lakomsky D; Serrano J; Alvarez MA; Martín C; Valls C; Nevado L; Rodriguez A; Casaño J; Martínez F; Gómez P
    Haematologica; 2001 Jan; 86(1):24-9. PubMed ID: 11146566
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bone marrow transplantation after failure of autologous transplant for non-Hodgkin's lymphoma.
    de Lima M; van Besien KW; Giralt SA; Khouri IF; Mehra R; Andersson BS; Przepiorka D; Gajewski JL; Korbling M; Champlin RE
    Bone Marrow Transplant; 1997 Jan; 19(2):121-7. PubMed ID: 9116608
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Circulating erythropoietin in patients with acquired aplastic anaemia.
    Kojima S; Matsuyama T; Kodera Y
    Acta Haematol; 1995; 94(3):117-22. PubMed ID: 7502626
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of pre-transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation.
    El-Jawahri A; Chen YB; Brazauskas R; He N; Lee SJ; Knight JM; Majhail N; Buchbinder D; Schears RM; Wirk BM; Wood WA; Ahmed I; Aljurf M; Szer J; Beattie SM; Battiwalla M; Dandoy C; Diaz MA; D'Souza A; Freytes CO; Gajewski J; Gergis U; Hashmi SK; Jakubowski A; Kamble RT; Kindwall-Keller T; Lazarus HM; Malone AK; Marks DI; Meehan K; Savani BN; Olsson RF; Rizzieri D; Steinberg A; Speckhart D; Szwajcer D; Schoemans H; Seo S; Ustun C; Atsuta Y; Dalal J; Sales-Bonfim C; Khera N; Hahn T; Saber W
    Cancer; 2017 May; 123(10):1828-1838. PubMed ID: 28102896
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relapsed acute lymphoblastic leukemia: similar outcomes for autologous and allogeneic marrow transplantation in selected children.
    Parsons SK; Castellino SM; Lehmann LE; Eickhoff CE; Tarbell NJ; Sallan SE; Weinstein HJ; Billett AL
    Bone Marrow Transplant; 1996 May; 17(5):763-8. PubMed ID: 8733695
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Bloodstream infections can develop late (after day 100) and/or in the absence of neutropenia in children receiving allogeneic bone marrow transplantation.
    Romano V; Castagnola E; Dallorso S; Lanino E; Calvi A; Silvestro S; Morreale G; Giacchino R; Dini G
    Bone Marrow Transplant; 1999 Feb; 23(3):271-5. PubMed ID: 10084259
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Bone marrow transplantation activity in Europe 1992: report from the European Group for Bone Marrow Transplantation (EBMT).
    Gratwohl A; Hermans J
    Bone Marrow Transplant; 1994 Jan; 13(1):5-10. PubMed ID: 8019452
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Allogeneic or autologous bone marrow transplantation for acute lymphoblastic leukemia in first complete remission.
    Blaise D; Gaspard MH; Stoppa AM; Michel G; Gastaut JA; Lepeu G; Tubiana N; Blanc AP; Rossi JF; Novakovitch G
    Bone Marrow Transplant; 1990 Jan; 5(1):7-12. PubMed ID: 2404531
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thrombocytopenia after bone marrow transplantation for leukaemia: changes in megakaryocyte growth and growth-promoting activity.
    Adams JA; Gordon AA; Jiang YZ; Macdonald D; McCarthy DM; Zuiable A; Treleaven J; Powles RL; Barrett AJ
    Br J Haematol; 1990 Jun; 75(2):195-201. PubMed ID: 2372505
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of autologous and allogeneic bone marrow transplantation for treatment of high-risk refractory acute lymphoblastic leukemia.
    Kersey JH; Weisdorf D; Nesbit ME; LeBien TW; Woods WG; McGlave PB; Kim T; Vallera DA; Goldman AI; Bostrom B
    N Engl J Med; 1987 Aug; 317(8):461-7. PubMed ID: 3302708
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Peripheral blood stem cell graft compared to bone marrow after reduced intensity conditioning regimens for acute leukemia: a report from the ALWP of the EBMT.
    Savani BN; Labopin M; Blaise D; Niederwieser D; Ciceri F; Ganser A; Arnold R; Afanasyev B; Vigouroux S; Milpied N; Hallek M; Cornelissen JJ; Schwerdtfeger R; Polge E; Baron F; Esteve J; Gorin NC; Schmid C; Giebel S; Mohty M; Nagler A
    Haematologica; 2016 Feb; 101(2):256-62. PubMed ID: 26565001
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Erythropoietin and erythropoiesis after kidney transplantation].
    Zadrazil J; Bachleda P; Grosmanová T; Zahálková J; Fingerová H; Petrová P; Novotný D
    Vnitr Lek; 1996 Aug; 42(8):540-4. PubMed ID: 8967023
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.
    Holtick U; Albrecht M; Chemnitz JM; Theurich S; Skoetz N; Scheid C; von Bergwelt-Baildon M
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD010189. PubMed ID: 24748537
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of the intensive care unit in children undergoing bone marrow transplantation with life-threatening complications.
    Díaz de Heredia C; Moreno A; Olivé T; Iglesias J; Ortega JJ
    Bone Marrow Transplant; 1999 Jul; 24(2):163-8. PubMed ID: 10455344
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circulating CFU-E during hematopoietic recovery after allogeneic bone marrow transplantation: relationship to erythroid engraftment.
    Vannucchi AM; Bosi A; Lombardini L; Grossi A; Bacci P; Guidi S; Saccardi R; Rossi-Ferrini P
    Exp Hematol; 1995 Dec; 23(13):1337-40. PubMed ID: 7498360
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Administration of recombinant human erythropoietin alpha before autologous stem cell transplantation reduces transfusion requirement in multiple myeloma patients.
    Martino M; Oliva E; Console G; Stelitano C; Fujo M; Messina G; Irrera G; Pucci G; Mandaglio R; Callea V; Nobile F; Iacopino P; Morabito F
    Support Care Cancer; 2005 Mar; 13(3):182-7. PubMed ID: 15480819
    [TBL] [Abstract][Full Text] [Related]  

  • 57. IL-6 and IL-8 response to erythropoietin therapy in radical hysterectomy.
    Hyllner M; Avall A; Bengtson JP; Bengtsson A
    Acta Anaesthesiol Scand; 2005 Jan; 49(1):47-51. PubMed ID: 15675981
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Soluble interferon-gamma receptor and interferon-gamma in patients undergoing allogeneic bone marrow transplantation for hematological malignancies.
    Toren A; Barak V; Novick D; Nagler A
    Cytokines Cell Mol Ther; 1997 Sep; 3(3):153-8. PubMed ID: 9426973
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
    Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
    Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Histological features of skin and rectal biopsy specimens after autologous and allogeneic bone marrow transplantation.
    Sviland L; Pearson AD; Eastham EJ; Hamilton PJ; Proctor SJ; Malcolm AJ
    J Clin Pathol; 1988 Feb; 41(2):148-54. PubMed ID: 3280605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.